Actively Enrolling Clinical Trials
Neovascular Age-related Macular Degeneration
A 2-year, phase 3, multicentre, randomised, parallel-group, sham-controlled, double-masked study. Primary efficacy will be determined at Week 52.
Completed Clinical Trials
- Topical LHA510 as Maintenance Therapy for Wet Macular Degeneration
- Ocriplasmin Research to Better Inform Treatment [ORBIT]
- Vascular Endothelial Growth Factor VEGF Trap Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration [AMD] - VIEW 1
- Diabetic Macular Edema and VEGF Trap-Eye: Investigation of Clinical Impact [DA VINCI] - Phase II/ Phase III
- Evaluation of Efficacy and Safety in Maintinaing Visual Acuity with Sequential Treatment of Neovascular AMD (LEVEL)
- Protein Kinase 3 [PKC] Inhibitor-Diabetic Retinopathy Phase 3 Study